Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „doxorubicin“
Suchtreffer
Begriffe & Kennungen
Nexavar · 4.5 · Doxorubicin/Irinotecan
Eintrag öffnenPolivy · 4.5 · Drug interactions of rituximab, bendamustine, cyclophosphamide, and doxorubicin in combination with polatuzuma
Eintrag öffnenPolivy · 4.5 · The pharmacokinetics (PK) of rituximab, bendamustine, cyclophosphamide, and doxorubicin are not affected by co
Eintrag öffnenSavene · 4.5 · Co-administration of doxorubicin (50 to 60 mg/m2) or epirubicin (60 to 100 mg/m2) did not affect dexrazoxane p
Eintrag öffnenTaxotere · 4.5 · 11 The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their co-adminis
Eintrag öffnenTaxotere · 4.5 · 144 The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their co-admini
Eintrag öffnenTaxotere · 4.5 · 189 The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their co-admini
Eintrag öffnenTaxotere · 4.5 · 55 The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their co-adminis
Eintrag öffnenTaxotere · 4.5 · The pharmacokinetics of docetaxel, doxorubicin and cyclophosphamide were not influenced by their co-administra
Eintrag öffnenTaxotere · 4.8 · Tabulated list of adverse reactions in breast cancer for TAXOTERE 75 mg/m² in combination with doxorubicin
Eintrag öffnenTaxotere · 4.8 · Tabulated list of adverse reactions in breast cancer for TAXOTERE 75 mg/m² in combination with doxorubicin
Eintrag öffnenTaxotere · 4.8 · Tabulated list of adverse reactions in breast cancer for TAXOTERE 75 mg/m² in combination with doxorubicin
Eintrag öffnenTaxotere · 4.8 · Tabulated list of adverse reactions in breast cancer for TAXOTERE 75 mg/m² in combination with doxorubicin
Eintrag öffnenTaxotere · 4.8 · Tabulated list of adverse reactions in breast cancer for TAXOTERE 75 mg/m² in combination with doxorubicin
Eintrag öffnenZolsketil pegylated liposomal · 4.3 · Doxorubicin pegylated liposomal must not be used to treat AIDS-KS that may be treated effectively with local t
Eintrag öffnenZolsketil pegylated liposomal · 4.5 · No formal medicinal product interaction studies have been performed with doxorubicin pegylated liposomal, alth
Eintrag öffnenZolsketil pegylated liposomal · 4.8 · Cardiac toxicity An increased incidence of congestive heart failure is associated with doxorubicin therapy at
Eintrag öffnenZolsketil pegylated liposomal · 4.8 · In the pivotal phase III trial versus doxorubicin, 58/509 (11.4%) randomised subjects (10 treated with doxorub
Eintrag öffnenZolsketil pegylated liposomal · 4.8 · Opportunistic infections Respiratory undesirable effects commonly occurred in clinical studies of doxorubicin
Eintrag öffnenZolsketil pegylated liposomal · 4.8 · Table 5: Adverse reactions in patients treated with doxorubicin pegylated liposomal
Eintrag öffnen